Redhill Biopharma
(NASDAQ:RDHL)
$0.89
-0.0598[-6.30%]
Last update: 11:46AM
Day High/Low0.89 - 0.94
52 Week High/Low0.62 - 11.18
Open / Close0.94 / -
Float / Outstanding- / 53.3M
Vol / Avg.619.6K / 2.1M
Mkt Cap47.4M
P/E-
50d Avg. Price1.09
Div / Yield-
Payout Ratio-
EPS-0.3
Total Float-

Redhill Biopharma (NASDAQ:RDHL), Quotes and News Summary

Redhill Biopharma (NASDAQ: RDHL)

Day High/Low0.89 - 0.94
52 Week High/Low0.62 - 11.18
Open / Close0.94 / -
Float / Outstanding- / 53.3M
Vol / Avg.619.6K / 2.1M
Mkt Cap47.4M
P/E-
50d Avg. Price1.09
Div / Yield-
Payout Ratio-
EPS-0.3
Total Float-
Sector: Health Care.Industry: Pharmaceuticals
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults, Talicia for the treatment of Helicobacter pylori infection in adults, and Aemcolo for the treatment of travelers' diarrhea in adults. Its key clinical late-stage development programs include RHB-104 for Crohn's disease; RHB-204, for pulmonary nontuberculous mycobacteria infections; RHB-102 (Bekinda) with positive results from a first Phase 3 study for acute gastroenteritis and gastritis; Opaganib (Yeliva); RHB-106, an encapsulated bowel preparation and RHB-107, a Phase 2-stage serine protease inhibitor targeting cancer and inflammatory gastrointestinal diseases.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-25
REV
Q1 2022Est.ActualSurprise
EPS-0.230-0.030 0.2000
REV24.300M18.236M-6.064M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Redhill Biopharma Questions & Answers

Q
How do I buy Redhill Biopharma (RDHL) stock?
A

You can purchase shares of Redhill Biopharma (NASDAQ: RDHL) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Redhill Biopharma's (RDHL) competitors?
Q
What is the target price for Redhill Biopharma (RDHL) stock?
A

The latest price target for Redhill Biopharma (NASDAQ: RDHL) was reported by HC Wainwright & Co. on Wednesday, September 15, 2021. The analyst firm set a price target for 21.00 expecting RDHL to rise to within 12 months (a possible 2259.55% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Redhill Biopharma (RDHL)?
A

The stock price for Redhill Biopharma (NASDAQ: RDHL) is $0.89 last updated Today at July 6, 2022, 3:46 PM UTC.

Q
Does Redhill Biopharma (RDHL) pay a dividend?
A

There are no upcoming dividends for Redhill Biopharma.

Q
When is Redhill Biopharma (NASDAQ:RDHL) reporting earnings?
A

Redhill Biopharma’s Q2 earnings are confirmed for Thursday, August 25, 2022.

Q
Is Redhill Biopharma (RDHL) going to split?
A

There is no upcoming split for Redhill Biopharma.

Q
What sector and industry does Redhill Biopharma (RDHL) operate in?
A

Redhill Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.